Toolkit Multisectoral Action Plan For Noncommunicable Diseases
Toolkit Multisectoral Action Plan For Noncommunicable Diseases
Toolkit Multisectoral Action Plan For Noncommunicable Diseases
for developing a
multisectoral action plan
for noncommunicable
diseases
Module 1.
Conducting a
comprehensive assessment
Toolkit
for developing a
multisectoral action plan
for noncommunicable
diseases
Module 1.
Conducting a
comprehensive assessment
Toolkit for developing a multisectoral action plan for noncommunicable diseases.
Module 1. Conducting a comprehensive assessment
ISBN 978-92-4-004349-7 (electronic version)
ISBN 978-92-4-004350-3 (print version)
© World Health Organization 2022
Some rights reserved. This work is available under the Creative Commons Attribution-
NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO;
https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Under the terms of this licence, you may copy, redistribute and adapt the work for non-
commercial purposes, provided the work is appropriately cited, as indicated below. In
any use of this work, there should be no suggestion that WHO endorses any specific
organization, products or services. The use of the WHO logo is not permitted. If you adapt
the work, then you must license your work under the same or equivalent Creative Commons
licence. If you create a translation of this work, you should add the following disclaimer
along with the suggested citation: “This translation was not created by the World Health
Organization (WHO). WHO is not responsible for the content or accuracy of this translation.
The original English edition shall be the binding and authentic edition”.
Any mediation relating to disputes arising under the licence shall be conducted in
accordance with the mediation rules of the World Intellectual Property Organization
(http://www.wipo.int/amc/en/mediation/rules/).
Suggested citation. Toolkit for developing a multisectoral action plan for noncommunicable
diseases. Module 1. Conducting a comprehensive assessment. Geneva: World Health
Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.
Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/
bookorders. To submit requests for commercial use and queries on rights and licensing, see
https://www.who.int/copyright.
Third-party materials. If you wish to reuse material from this work that is attributed to a
third party, such as tables, figures or images, it is your responsibility to determine whether
permission is needed for that reuse and to obtain permission from the copyright holder. The
risk of claims resulting from infringement of any third-party-owned component in the work
rests solely with the user.
General disclaimers. The designations employed and the presentation of the material in
this publication do not imply the expression of any opinion whatsoever on the part of WHO
concerning the legal status of any country, territory, city or area or of its authorities, or
concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps
represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that
they are endorsed or recommended by WHO in preference to others of a similar nature that
are not mentioned. Errors and omissions excepted, the names of proprietary products are
distinguished by initial capital letters.
All reasonable precautions have been taken by WHO to verify the information contained in
this publication. However, the published material is being distributed without warranty of
any kind, either expressed or implied. The responsibility for the interpretation and use of the
material lies with the reader. In no event shall WHO be liable for damages arising from its use.
Contents
Acknowledgements v
1. Introduction 1
References 11
Resources 11
v
Epidemiology and Health Promotion, National Public Health Institute,
Helsinki, Finland; Gonghuan Yang, Chinese Centre for Disease Control and
Prevention, Beijing, China; Dr Yusharmen, Noncommunicable Diseases
Control, Directorate-General of Disease Control & Environmental Health,
Ministry of Health, Indonesia; Joizica Maucec Zakotnik, Countrywide
Integrated Noncommunicable Diseases Intervention Programme,
Community Health Centre, Slovenia; and Juan Zhang, Division of
NCD Prevention and Control, Chinese Center for Disease Control and
Prevention, China.
Thanks are also due to the following experts, who reviewed the toolkit and
provided technical assistance at different stages: Jawad Al-Lawati, Aulikki
Nissinen, Nancy Porteous, Pekka Puska and Sylvie Stachenko.
The following WHO staff (past and present) also contributed to the toolkit:
Robert Beaglehole, Francesco Branca, Patrick Chong, Jean-Marie Dangou,
Mathilde Elizabeth de Bruin, Allisa Deloge, Ibtihal Fadhil, Dongbo Fu,
Gauden Galea, Paolo Hartmann, Barbara Hjalsted, James Hospedales,
Branka Legetic, Sidi Allal Louzani, Chizuru Nishida, Armando Peruga,
Vladimir Poznyak, Gojka Roglic, Natalie Rosseau, Boureima Hama Sambo,
Cherian Varghese, Temo Waqanivalu, Di Wu, Ran Zhang and Yuxi Zhang.
WHO gratefully acknowledges the financial support of the Governments of
Finland, Netherlands and the Republic of Korea towards the development
and publication of this toolkit, as well as that of the Department of Health,
Hong Kong SAR, China and the Public Health Agency of Canada.
vi
1. Introduction
Overview
Mortality
Mortality data indicate the number of deaths by place, time and cause.
The methodology used to measure mortality depends on the capacity
of the country. Strengthening vital registration is essential to achieving
quality mortality data. However, where vital registration is unavailable,
or inadequate, from the perspective of coverage and/or quality, it is
acceptable to use alternative methods, such as verbal autopsy.
Morbidity
Morbidity data provide important information for the management of
health care systems, in particular the planning and evaluation of service
delivery. They are useful for the estimation of disease burden, gaps in
health system capacity, and the identification of missed opportunities in
prevention. They also provide critical information for the evaluation of
quality of care, and the production of cost estimates of NCDs to the health
system and individuals.
The principal methods for collecting morbidity data include population-
based disease registries, hospital-based registries, cross-sectional surveys,
cohort studies and technology that links records routinely collected by
health and administrative data systems.
Cancer registries are important because cancer type and staging are
critical in the planning of health care services, and to the quality of
care assessment and prevention programmes. For this reason, cancer
registration has been included in the global NCD monitoring framework.
The inclusion of indicators of acute myocardial infarction, stroke, chronic
obstructive pulmonary disease, asthma, diabetes, and kidney and liver
disease will depend on a country’s technical and economic capacity, as well
as the priority assigned to these conditions. Surveys and/or hospital-based
data are recommended for these morbidity indicators.
Data sources
Disease incidence can be assessed through population-based disease
registries and/or hospital-based registries, where feasible. Record linkage
can be used to calculate incidence from routinely collected health and
administrative data systems. Prevalence rates of the main NCD risk factors
can be assessed through WHO STEPS surveys, tobacco surveys or similar
health surveys representative of the national or sub-national levels. Case
fatality and survival rates are derived from statistical analysis of disease
registry and hospital-based data. (See Resources section.)
2.3.3 Capacity of the health system for NCD prevention and control
Health service
An assessment of health sector capacity is key to determining its ability
to tackle NCD prevention and control. It is important to consider the
capacities of both the public and the private health sector in relation to
NCD prevention and management. For both, the following components
require assessment:
—— physical and organizational infrastructure
—— appropriate equipment, medicines and technology
—— numbers and extent of training of appropriate personnel
—— availability of practice guidelines for specific NCD conditions and risk
factor management
—— distribution of services and personnel
—— access to services with regard to chronic conditions.
Assessment of primary care services is also required, in terms of:
—— health promotion and primary prevention
—— surveillance
—— management of risk factors
—— treatment of the main NCDs
—— palliative care and home-based care
—— patient education, self-care
—— counselling.
Financial resources
A situation analysis should consider the potential sources of financial
resources to support NCD policies and programmes and the potential for
financial and in-kind support from other sectors and stakeholders that
have an interest in health, such as:
—— government departments and agencies
—— international and national NGOs
—— national and international philanthropic organizations
—— research funding agencies
—— health charities
—— private sector, e.g. insurance companies.
Research capacity
A national NCD policy and a plan need to be informed by evidence.
Addressing gaps in this evidence can be greatly assisted by applied, policy-
driven research. A situation analysis should therefore include, as far as
possible, an assessment of research capacity that could potentially be
harnessed to support NCD prevention and control.
A situation analysis can include an assessment of basic clinical,
epidemiological and implementation research, and can target particular
population groups and settings. The analysis should also provide
information on possible gaps in research training, methodology
development and how research results are used and disseminated. In
particular, research capacity includes research on methods and theories
of implementation that can be applied to identify gaps in implementation
of the existing evidence-based interventions, technical guidelines and
barriers, and facilitators. Research can also help to develop implementation
strategies to address these issues in order to improve the implementation.
Community capacity
Assessment of community capacity includes the following areas:
—— public awareness and health literacy with regard to NCD prevention and
control;
—— the existence of supportive networks, for example patient associations;
—— the existence of supportive local environments, for example school
programmes and municipal or local initiatives and facilities, including
recreational facilities;
—— a supply of supportive services, including water supply and sanitation;
—— adequate safety measures in the local environment; and
—— the existence of community leaders and champions to help motivate
behavioural change.
Resources
Blas E, Sivasankara Kurup A, editors (2010). Equity, social determinants and public health
programmes. Geneva: World Health Organization
(https://apps.who.int/iris/handle/10665/44289).
Commission on Social Determinants of Health (2008). Closing the gap in a generation:
health equity through action on the social determinants of health. Final report: executive
summary. Geneva: World Health Organization (WHO/IER/CSDH/08.1;
https://apps.who.int/iris/handle/10665/69832).
UN (2011). Political declaration of the high-level meeting of the General Assembly on the
prevention and control of non-communicable diseases. New York: United Nations (A/
RES/66/2; https://digitallibrary.un.org/record/710899/?ln=en).
UN (2018). Political declaration of the Third High-level Meeting of the General Assembly
on the Prevention and Control of Non-communicable Diseases. New York: United
Nations (A/RES/73/2; https://digitallibrary.un.org/record/1648984?ln=en).
WHO. Global Health Observatory (GHO) [online database]. Geneva: World Health
Organization (https://www.who.int/data/gho/data/themes/noncommunicable-diseases).
WHO. Health accounts [online resource]. Geneva: World Health Organization
(https://www.who.int/health-topics/health-accounts#tab=tab_1).
WHO. Social determinants of health [website]. Geneva: World Health Organization
(https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1, accessed 1
November 2021).
WHO. STEPwise approach to NCD risk factor surveillance (STEPS) [online tool] (https://
www.who.int/teams/noncommunicable-diseases/surveillance/systems-tools/steps).
WHO (2008). 2008–2013 Action plan for the global strategy for the prevention and
control of noncommunicable diseases. Geneva: World Health Organization
(https://www.who.int/nmh/publications/ncd_action_plan_en.pdf).
WHO (2013). Global action plan for the prevention and control of noncommunicable
diseases 2013–20. Geneva: World Health Organization (https://apps.who.int/iris/
handle/10665/94384).
WHO (2018). Time to deliver: report of the WHO Independent High-level Commission on
Noncommunicable Diseases. Geneva: World Health Organization (https://apps.who.int/
iris/handle/10665/272710).
WHO (2019). Global health estimates [online database]. Geneva: World Health
Organization (https://www.who.int/data/global-health-estimates).
Profile of area
—— Describe the status of the population and provide the main health
indicators.
—— Describe the status of economic and health expenditure.
CHECKLIST
✤✤ Use the Checklist available here to make sure you have
completed all the necessary steps before moving on to the next
module.